Baidu
map

2014年“诺奖风向标”盖尔德纳奖揭晓

2014-03-27 佚名 生物360

日前,有诺贝尔生理学或医学奖风向标之称的 2014 年加拿大盖尔德纳奖(Gairdner Award)揭晓,今年的获奖者向世界展示了来自心血管疾病、癌症、免疫疗法以及人类寄生虫病等领域的新发现。 盖尔德纳国际奖(Canada Gairdner International Awards): 德克萨斯大学MD安德森癌症中心免疫学主任 James P. Allison获奖原因:因其发现免疫检查点封锁

日前,有诺贝尔生理学或医学奖风向标之称的 2014 年加拿大盖尔德纳奖(Gairdner Award)揭晓,今年的获奖者向世界展示了来自心血管疾病、癌症、免疫疗法以及人类寄生虫病等领域的新发现。

盖尔德纳国际奖(Canada Gairdner International Awards):

免疫学主任 James P. Allison

来自德克萨斯大学MD安德森癌症中心

获奖原因:因其发现免疫检查点封锁方法并成功将其应用癌症的免疫疗法中

细胞生物学和遗传学实验室主任 Titia de Lange

来自美国癌症协会教授、洛克菲勒大学安德森癌症研究中心

获奖原因:因其发现哺乳动物端粒有助于DNA修复损伤的应答机制

病理学教授 Harold Fisher Dvorak以及Napoleone Ferrara

分别来自于哈佛医学院以色列女执事医疗中心以及加州大学圣地亚哥分校穆尔斯癌症中心

获奖原因:因他们发现一种可在体内诱导血管新生的内皮生长因子(VEGF),并研发出抗内皮生长因子从而来治疗癌症以及湿性黄斑变性等病症

风湿病学研究所教授 Marc Feldmann以及Ravinder Nath Maini

分别来自于牛津大学肯尼迪以及牛津大学肯尼迪风湿病学研究所

获奖原因:因其发现用于治疗风湿性关节炎和其他炎症性疾病的鼠抗人肿瘤坏死因子(anti-TNF)

盖尔德纳全球健康奖( Canada Gairdner Global Health Award):

Satoshi Omura

来自东京北里大学药物发现科学学院

获奖原因:因其发现微生物链霉菌属微生物Streptomyces avermitilis以及其生物学特性,从而帮助默克公司鉴定出阿维菌素(avermectin)和开发出伊维菌(ivermectin)。两种药物成功治疗许多寄生虫病以及在全球范围消除河盲症。

盖尔德纳怀特曼奖(Canada Gairdner Wightman Award):

来自麦克马斯特大学的医学教授,人口健康研究所主任,汉密尔顿健康科学中心、医院以及 David Braley 研究所副总裁 Salim Yusuf

获奖原因:在心血管疾病领域的全球范围临床试验以及人口研究中,表现出卓越的领导能力,并制定最佳的预防和治疗指南。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2034371, encodeId=2bfd20343e1f6, content=<a href='/topic/show?id=230691926f9' target=_blank style='color:#2F92EE;'>#诺奖风向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91926, encryptionId=230691926f9, topicName=诺奖风向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db7c233, createdName=changjitao2009, createdTime=Wed Mar 04 06:55:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800279, encodeId=7bf918002e9c8, content=<a href='/topic/show?id=f650e236615' target=_blank style='color:#2F92EE;'>#盖尔德纳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72366, encryptionId=f650e236615, topicName=盖尔德纳)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Sat Dec 27 10:55:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462241, encodeId=358314622419d, content=<a href='/topic/show?id=5c0c9191e10' target=_blank style='color:#2F92EE;'>#诺奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91917, encryptionId=5c0c9191e10, topicName=诺奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Mar 29 09:55:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8710, encodeId=f19d8e10b3, content=这篇文章很垃圾, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=111, createdTime=Fri Mar 28 13:57:00 CST 2014, time=2014-03-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2034371, encodeId=2bfd20343e1f6, content=<a href='/topic/show?id=230691926f9' target=_blank style='color:#2F92EE;'>#诺奖风向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91926, encryptionId=230691926f9, topicName=诺奖风向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db7c233, createdName=changjitao2009, createdTime=Wed Mar 04 06:55:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800279, encodeId=7bf918002e9c8, content=<a href='/topic/show?id=f650e236615' target=_blank style='color:#2F92EE;'>#盖尔德纳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72366, encryptionId=f650e236615, topicName=盖尔德纳)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Sat Dec 27 10:55:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462241, encodeId=358314622419d, content=<a href='/topic/show?id=5c0c9191e10' target=_blank style='color:#2F92EE;'>#诺奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91917, encryptionId=5c0c9191e10, topicName=诺奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Mar 29 09:55:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8710, encodeId=f19d8e10b3, content=这篇文章很垃圾, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=111, createdTime=Fri Mar 28 13:57:00 CST 2014, time=2014-03-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2034371, encodeId=2bfd20343e1f6, content=<a href='/topic/show?id=230691926f9' target=_blank style='color:#2F92EE;'>#诺奖风向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91926, encryptionId=230691926f9, topicName=诺奖风向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db7c233, createdName=changjitao2009, createdTime=Wed Mar 04 06:55:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800279, encodeId=7bf918002e9c8, content=<a href='/topic/show?id=f650e236615' target=_blank style='color:#2F92EE;'>#盖尔德纳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72366, encryptionId=f650e236615, topicName=盖尔德纳)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Sat Dec 27 10:55:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462241, encodeId=358314622419d, content=<a href='/topic/show?id=5c0c9191e10' target=_blank style='color:#2F92EE;'>#诺奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91917, encryptionId=5c0c9191e10, topicName=诺奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Mar 29 09:55:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8710, encodeId=f19d8e10b3, content=这篇文章很垃圾, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=111, createdTime=Fri Mar 28 13:57:00 CST 2014, time=2014-03-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2034371, encodeId=2bfd20343e1f6, content=<a href='/topic/show?id=230691926f9' target=_blank style='color:#2F92EE;'>#诺奖风向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91926, encryptionId=230691926f9, topicName=诺奖风向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db7c233, createdName=changjitao2009, createdTime=Wed Mar 04 06:55:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800279, encodeId=7bf918002e9c8, content=<a href='/topic/show?id=f650e236615' target=_blank style='color:#2F92EE;'>#盖尔德纳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72366, encryptionId=f650e236615, topicName=盖尔德纳)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Sat Dec 27 10:55:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462241, encodeId=358314622419d, content=<a href='/topic/show?id=5c0c9191e10' target=_blank style='color:#2F92EE;'>#诺奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91917, encryptionId=5c0c9191e10, topicName=诺奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Mar 29 09:55:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8710, encodeId=f19d8e10b3, content=这篇文章很垃圾, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=111, createdTime=Fri Mar 28 13:57:00 CST 2014, time=2014-03-28, status=1, ipAttribution=)]
    2014-03-28 111

    这篇文章很垃圾

    0

Baidu
map
Baidu
map
Baidu
map